Evidence map›Paper›PMID 39395090›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2024

Hepatitis E virus prevalence among HIV-2 infected individuals in central Portugal.

João Pereira-Vaz, Anália Carmo, Vítor Duque, Cristina Luxo, Ana Alves, Alexandra Mendes, Célia Morais, Cláudio Gaspar, Raquel Costa, Lurdes Correia and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

João Pereira-VazLaboratory of Virology, Clinical Pathology Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Avenida Afonso Romão, Coimbra, 3000-602, Portugal. joaovaz@ulscoimbra.min-saude.pt.ORCID http://orcid.org/0000-0002-1444-4097
Anália CarmoLaboratory of Virology, Clinical Pathology Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Avenida Afonso Romão, Coimbra, 3000-602, Portugal.
Vítor DuqueInfectious Diseases Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Coimbra, Portugal.
Cristina LuxoCERES, University of Coimbra, Coimbra, Portugal.
Ana AlvesLaboratory of Virology, Clinical Pathology Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Avenida Afonso Romão, Coimbra, 3000-602, Portugal.
Alexandra MendesLaboratory of Virology, Clinical Pathology Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Avenida Afonso Romão, Coimbra, 3000-602, Portugal.
Célia MoraisLaboratory of Virology, Clinical Pathology Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Avenida Afonso Romão, Coimbra, 3000-602, Portugal.
Cláudio GasparLaboratory of Virology, Clinical Pathology Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Avenida Afonso Romão, Coimbra, 3000-602, Portugal.
Raquel CostaLaboratory of Virology, Clinical Pathology Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Avenida Afonso Romão, Coimbra, 3000-602, Portugal.
Lurdes CorreiaLaboratory of Virology, Clinical Pathology Department, Centro Hospitalar e Universitário de Coimbra, Unidade Local de Saúde de Coimbra, Avenida Afonso Romão, Coimbra, 3000-602, Portugal.
Fernando RodriguesFaculty of Medicine, University of Coimbra, Coimbra, Portugal.
Ana MatosCERES, University of Coimbra, Coimbra, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To date, no studies comparing the prevalence of hepatitis E virus (HEV) infection between the general and human immunodeficiency virus 2 (HIV-2) populations are available. With the purpose of filling this gap, this prevalence was assessed in the HIV-2 population from central Portugal. HEV seropositivity was 19.4%, which did not differ significantly from that found in the matched control population, and was not associated with CD4 cell count, HIV-2 viral load, and geographic origin or travel history to regions considered highly endemic for HEV. The results suggest that HIV-2 is not a risk factor for HEV infection, neither for an increased occurrence of chronic HEV infection.

Indexed as

Hepatitis EHepatitis E virusHIV-2HIV InfectionsAdultCD4 Lymphocyte CountCoinfectionFemaleHepatitis AntibodiesHumansMaleMiddle AgedPortugalPrevalenceRisk FactorsSeroepidemiologic StudiesHepatitis AntibodiesHEVHIV-2PortugalPrevalence

Identifiers

PMID39395090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.